Famciclovir (NorthStar RxLLC)
Welcome to the PulseAid listing for the Famciclovir drug offered from NorthStar RxLLC. This DNA Polymerase Inhibitors [MoA],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | NorthStar RxLLC |
NON-PROPRIETARY NAME: | Famciclovir |
SUBSTANCE NAME: | FAMCICLOVIR |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | DNA Polymerase Inhibitors [MoA],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-02-01 |
END MARKETING DATE: | 0000-00-00 |
Famciclovir HUMAN PRESCRIPTION DRUG Details:
Item Description | Famciclovir from NorthStar RxLLC |
LABELER NAME: | NorthStar RxLLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 125(mg/1) |
START MARKETING DATE: | 2017-02-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 16714-614_a0944b55-eb75-4a39-bc79-4bf183408604 |
PRODUCT NDC: | 16714-614 |
APPLICATION NUMBER: | ANDA078278 |
Other FAMCICLOVIR Pharmaceutical Manufacturers / Labelers: